Dr. Matthew Phillip MacFarlane, MD

Dr. MacFarlane practices at Los Angeles General Medical Center in Los Angeles, California.

Dr. MacFarlane's NPI, 1285123067, was assigned on May 7, 2018. Dr. MacFarlane graduated from Lewis Katz School of Medicine in 2018. Dr. MacFarlane's California license number on file is A165959.

Dr. MacFarlane's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 409-2800.

Dr. MacFarlane's primary practice is Los Angeles General Medical Center in Los Angeles, California. Dr. MacFarlane is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. MacFarlane to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. MacFarlane practices. Vendor and product names are available with a free account.

Internal medicine is Dr. MacFarlane's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. MacFarlane is board certified in internal medicine by the American Board of Internal Medicine. Dr. MacFarlane has a license on file in California.

Dmand AI lists acid reflux, acute kidney failure, cardiomyopathy, carpal tunnel syndrome, cerebrovascular disease, chronic anemia, chronic diabetes and chronic hypertension among the conditions Dr. MacFarlane treats.

CMS data shows 705 Medicare services from Dr. MacFarlane across 12 procedure codes in 2024, for 219 Medicare patients. Medicare paid $51,751 for them. Every service was in an office.

CMS counts 219 Medicare patients who saw Dr. MacFarlane in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. MacFarlane's median patient age at 54, with 44% women.

In 2024, Dr. MacFarlane wrote 1,058 Medicare Part D claims for 210 patients. 77% of them were for generic drugs. CMS names the drug for 609 of them, across 26 drugs with 11 or more claims each, at $343,358 in total drug cost. In 2023, CMS named 336 claims across 16 drugs.

Dr. MacFarlane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. MacFarlane as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. MacFarlane in 2014. The most frequent topics are Case Management and Malaria. Dr. MacFarlane's most frequent co-authors are Demetri A. Blanas, MD and Andrew Stuart Kanter, MD, MPH.

CMS Open Payments shows 9 general payments to Dr. MacFarlane from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. ViiV Healthcare Company paid the most, $162.

Dr. MacFarlane graduated from Lewis Katz School of Medicine in 2018.

Dr. MacFarlane is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.